Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 120

1.

A study evaluating poliovirus antibodies and risk factors associated with polio seropositivity in low socioeconomic areas of Pakistan.

Habib M, Soofi S, Ali N, Sutter RW, Palansch M, Qureshi H, Akhtar T, Molodecky NA, Okayasu H, Bhutta ZA.

Vaccine. 2013 Apr 8;31(15):1987-93. doi: 10.1016/j.vaccine.2013.02.003. Epub 2013 Feb 18.

PMID:
23429005
[PubMed - indexed for MEDLINE]
2.

Survey of poliovirus antibodies during the final stage of polio eradication in Egypt.

El-Sayed N, Al-Jorf S, Hennessey KA, Salama M, Watkins MA, Abdelwahab JA, Pallansch MA, Gary H, Wahdan MH, Sutter RW.

Vaccine. 2007 Jun 28;25(27):5062-70. Epub 2007 Apr 25.

PMID:
17543428
[PubMed - indexed for MEDLINE]
3.

Population immunity to polioviruses in the context of a large-scale wild poliovirus type 1 outbreak in Tajikistan, 2010.

Khetsuriani N, Pallansch MA, Jabirov S, Saparova N, Oberste MS, Wannemuehler K, Ursu P, Wassilak S, Martin R.

Vaccine. 2013 Oct 1;31(42):4911-6. doi: 10.1016/j.vaccine.2013.06.106. Epub 2013 Jul 24.

PMID:
23891502
[PubMed - indexed for MEDLINE]
4.

Immunogenicity of oral poliovirus vaccine administered in mass campaigns versus routine immunization programmes.

Richardson G, Linkins RW, Eames MA, Wood DJ, Campbell PJ, Ankers E, Deniel M, Kabbaj A, Magrath DI, Minor PD, et al.

Bull World Health Organ. 1995;73(6):769-77.

PMID:
8907770
[PubMed - indexed for MEDLINE]
Free PMC Article
5.

The effect of mass immunisation campaigns and new oral poliovirus vaccines on the incidence of poliomyelitis in Pakistan and Afghanistan, 2001-11: a retrospective analysis.

O'Reilly KM, Durry E, ul Islam O, Quddus A, Abid N, Mir TP, Tangermann RH, Aylward RB, Grassly NC.

Lancet. 2012 Aug 4;380(9840):491-8. doi: 10.1016/S0140-6736(12)60648-5. Epub 2012 Jul 4.

PMID:
22766207
[PubMed - indexed for MEDLINE]
Free PMC Article
6.

Paralytic poliomyelitis in Oman: association between regional differences in attack rate and variations in antibody responses to oral poliovirus vaccine.

Sutter RW, Patriarca PA, Suleiman AJ, Pallansch MA, Zell ER, Malankar PG, Brogan S, al-Ghassani AA, el-Bualy MS.

Int J Epidemiol. 1993 Oct;22(5):936-44.

PMID:
8282476
[PubMed - indexed for MEDLINE]
7.

Seroprevalence of antibody against poliovirus in inner-city preschool children. Implications for vaccination policy in the United States.

Chen RT, Hausinger S, Dajani AS, Hanfling M, Baughman AL, Pallansch MA, Patriarca PA.

JAMA. 1996 Jun 5;275(21):1639-45.

PMID:
8637136
[PubMed - indexed for MEDLINE]
8.

Seroprevalence of poliovirus antibodies amongst children in Zaria, Northern Nigeria.

Giwa FJ, Olayinka AT, Ogunshola FT.

Vaccine. 2012 Nov 6;30(48):6759-65. doi: 10.1016/j.vaccine.2012.09.023. Epub 2012 Sep 20.

PMID:
23000220
[PubMed - indexed for MEDLINE]
9.
10.

Seroprevalence of anti-polio antibodies in a population 7 months to 39 years of age in Uruguay: Implications for future polio vaccination strategies.

Pírez MC, Olivera I, Diabarboure H, Montano A, Barañano R, Badía F, Bonnet MC.

Vaccine. 2009 May 5;27(20):2689-94. doi: 10.1016/j.vaccine.2009.02.042. Epub 2009 Feb 24.

PMID:
19428880
[PubMed - indexed for MEDLINE]
11.

Sequential use of inactivated poliovirus vaccine followed by oral poliovirus vaccine in Oman.

Sutter RW, Suleiman AJ, Malankar PG, Mehta FR, Medany MA, Arif MA, Linkins RW, Pallansch MA, El-Bualy MS, Robertson SE.

J Infect Dis. 1997 Feb;175 Suppl 1:S235-40.

PMID:
9203722
[PubMed - indexed for MEDLINE]
Free Article
12.

Deficiency of immunity to poliovirus type 3: a lurking danger?

Reinheimer C, Friedrichs I, Rabenau HF, Doerr HW.

BMC Infect Dis. 2012 Jan 26;12:24. doi: 10.1186/1471-2334-12-24.

PMID:
22280025
[PubMed - indexed for MEDLINE]
Free PMC Article
13.

Effect of diarrhea on the humoral response to oral polio vaccination.

Myaux JA, Unicomb L, Besser RE, Modlin JF, Uzma A, Islam AM, Santosham M.

Pediatr Infect Dis J. 1996 Mar;15(3):204-9.

PMID:
8852907
[PubMed - indexed for MEDLINE]
14.

Survey of poliovirus antibodies in Kano, Northern Nigeria.

Iliyasu Z, Nwaze E, Verma H, Mustapha AO, Weldegebriel G, Gasasira A, Wannemuehler KA, Pallansch MA, Gajida AU, Pate M, Sutter RW.

Vaccine. 2014 Mar 10;32(12):1414-20. doi: 10.1016/j.vaccine.2013.08.060. Epub 2013 Sep 14.

PMID:
24041545
[PubMed - indexed for MEDLINE]
15.

Virological and serological studies on poliomyelitis in Karachi, Pakistan. I. Outbreaks in 1990-91.

Isomura S, Mubina A, Dure-Samin A, Isihara Y, Sakae K, Yamashita T, Nishio O, Ahmed A.

Acta Paediatr Jpn. 1993 Oct;35(5):382-6.

PMID:
8256620
[PubMed - indexed for MEDLINE]
16.

Immunogenicity of supplemental doses of poliovirus vaccine for children aged 6-9 months in Moradabad, India: a community-based, randomised controlled trial.

Estívariz CF, Jafari H, Sutter RW, John TJ, Jain V, Agarwal A, Verma H, Pallansch MA, Singh AP, Guirguis S, Awale J, Burton A, Bahl S, Chatterjee A, Aylward RB.

Lancet Infect Dis. 2012 Feb;12(2):128-35. doi: 10.1016/S1473-3099(11)70190-6. Epub 2011 Nov 7.

PMID:
22071249
[PubMed - indexed for MEDLINE]
17.

Interrupting wild poliovirus transmission using oral poliovirus vaccine: environmental surveillance in high-risks area of India.

Chowdhary R, Dhole TN.

J Med Virol. 2008 Aug;80(8):1477-88. doi: 10.1002/jmv.21230.

PMID:
18551602
[PubMed - indexed for MEDLINE]
18.

Immune response to an intercalated enhanced inactivated polio vaccine/oral polio vaccine programme in Israel: impact on the control of poliomyelitis.

Swartz TA, Handsher R, Manor Y, Stoeckel P, Barkay A, Mendelson E, Leventhal A.

Vaccine. 1998 Dec;16(20):2090-5.

PMID:
9796069
[PubMed - indexed for MEDLINE]
19.

Immunity against poliomyelitis in the Netherlands, assessed in 2006 to 2007: the importance of completing a vaccination series.

van der Maas NA, Mollema L, Berbers GA, van Rooijen DM, van der Avoort HG, Conyn-Van Spaendonck MA, de Melker HE, van der Klis FR.

Euro Surveill. 2014 Feb 20;19(7):20705.

PMID:
24576472
[PubMed - indexed for MEDLINE]
Free Article
20.

Epidemiological analysis of immunity to poliovirus after termination of an era of vaccination with OPV in Germany. An analysis of the German Association Against Viral Diseases (DVV).

Franck S, Allwinn R, Rabenau HF, Doerr HW.

Zentralbl Bakteriol. 1999 Oct;289(4):475-81.

PMID:
10603664
[PubMed - indexed for MEDLINE]

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk